Cargando…

A High Body Mass Index in Esophageal Cancer Patients Does Not Influence Postoperative Outcome or Long-Term Survival

BACKGROUND: The body mass index (BMI) in the general population has increased over the past decades. A high BMI is a known risk factor for the development of esophageal adenocarcinoma. Several studies on the influence of a high BMI on the postoperative course and survival after esophagectomy have sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blom, R. L. G. M., Lagarde, S. M., Klinkenbijl, J. H. G., Busch, O. R. C., van Berge Henegouwen, M. I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278623/ https://www.ncbi.nlm.nih.gov/pubmed/21979112 http://dx.doi.org/10.1245/s10434-011-2103-7

Ejemplares similares

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival
por: Pultrum, B. B., et al.
Publicado: (2010)

A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit
por: van der Werf, L. R., et al.
Publicado: (2018)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study
por: Borgstein, Alexander B. J., et al.
Publicado: (2021)

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer
por: de Heer, E. C., et al.
Publicado: (2017)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer
por: van der Werf, Leonie R., et al.
Publicado: (2019)

Is there a Benefit of Multidisciplinary Cancer Team Meetings for Patients with Gastrointestinal Malignancies?
por: Basta, Yara L., et al.
Publicado: (2016)

Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer
por: Drake, Justin A., et al.
Publicado: (2020)

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study
por: Voeten, Daan M., et al.
Publicado: (2021)

Vitamin Status and the Development of Postoperative Cognitive Decline in Elderly Surgical Oncologic Patients
por: Weerink, Linda B. M., et al.
Publicado: (2017)

Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer
por: Faiz, Zohra, et al.
Publicado: (2018)

A Critical Appraisal of Circumferential Resection Margins in Esophageal Carcinoma
por: Pultrum, Bareld B., et al.
Publicado: (2009)

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review
por: Wang, H. H., et al.
Publicado: (2023)

Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists
por: Verhoef, Christian, et al.
Publicado: (2007)

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
por: van de Schoot, L., et al.
Publicado: (2007)

Surgery for Esophageal Cancer: Quality of Life Matters
por: Salo, Jonathan C
Publicado: (2009)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy
por: Markar, Sheraz R., et al.
Publicado: (2017)

Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy
por: Xiao, Hua, et al.
Publicado: (2020)

Postoperative Inflammatory Marker Surveillance in Colorectal Peritoneal Carcinomatosis
por: Thiagarajan, Sasinthiran, et al.
Publicado: (2021)

Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers
por: Black, Douglas, et al.
Publicado: (2017)

High-Volume versus Low-Volume for Esophageal Resections for Cancer: The Essential Role of Case-Mix Adjustments based on Clinical Data
por: Wouters, Michael W., et al.
Publicado: (2007)

Preoperative Cardiopulmonary Exercise Test Associated with Postoperative Outcomes in Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analyses
por: Steffens, Daniel, et al.
Publicado: (2021)

Elucidation of the Anatomical Mechanism of Nodal Skip Metastasis in Superficial Thoracic Esophageal Squamous Cell Carcinoma
por: Kumakura, Yuji, et al.
Publicado: (2018)

Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer
por: Gottlieb-Vedi, Eivind, et al.
Publicado: (2018)

Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
por: van Heijl, Mark, et al.
Publicado: (2009)

Prognostic Value of Postoperative CEA Clearance in Rectal Cancer Patients with High Preoperative CEA Levels
por: Kim, Jeong Yeon, et al.
Publicado: (2009)

Diagnostic Performance of Artificial Intelligence-Centred Systems in the Diagnosis and Postoperative Surveillance of Upper Gastrointestinal Malignancies Using Computed Tomography Imaging: A Systematic Review and Meta-Analysis of Diagnostic Accuracy
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Embedded Cervical Esophagogastrostomy: A Simple and Convenient Method Using a Circular Stapler After Esophagectomy for Esophageal Carcinomas
por: Wu, Sen, et al.
Publicado: (2013)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
por: Katz, Matthew H. G., et al.
Publicado: (2010)

Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer
por: Beukinga, Roelof J., et al.
Publicado: (2020)

Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma
por: Kollmann, Dagmar, et al.
Publicado: (2017)

Physiotherapy With Telerehabilitation in Patients With Complicated Postoperative Recovery After Esophageal Cancer Surgery: Feasibility Study
por: van Egmond, Maarten A, et al.
Publicado: (2020)

Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden
por: Asplund, Johannes, et al.
Publicado: (2018)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)

Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy
por: Leinwand, Joshua C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s8q5ga7lu8sj5vdcmdn12lr1aq